S&P 500   3,082.70 (-1.08%)
DOW   26,627.70 (-1.22%)
QQQ   213.13 (-1.55%)
AAPL   283.04 (-3.28%)
FB   194.40 (-1.42%)
MSFT   165.60 (-2.69%)
GOOGL   1,360.73 (-2.14%)
AMZN   1,952.53 (-1.37%)
CGC   19.07 (-3.78%)
NVDA   263.90 (-1.40%)
MU   52.31 (-0.11%)
TSLA   713.98 (-8.32%)
AMD   45.25 (-4.72%)
T   36.63 (-1.27%)
ACB   1.49 (-1.32%)
F   7.22 (+0.14%)
NFLX   388.01 (+2.31%)
PRI   119.78 (-0.30%)
BAC   30.08 (-1.80%)
DIS   122.46 (-0.73%)
GILD   73.78 (-1.23%)
S&P 500   3,082.70 (-1.08%)
DOW   26,627.70 (-1.22%)
QQQ   213.13 (-1.55%)
AAPL   283.04 (-3.28%)
FB   194.40 (-1.42%)
MSFT   165.60 (-2.69%)
GOOGL   1,360.73 (-2.14%)
AMZN   1,952.53 (-1.37%)
CGC   19.07 (-3.78%)
NVDA   263.90 (-1.40%)
MU   52.31 (-0.11%)
TSLA   713.98 (-8.32%)
AMD   45.25 (-4.72%)
T   36.63 (-1.27%)
ACB   1.49 (-1.32%)
F   7.22 (+0.14%)
NFLX   388.01 (+2.31%)
PRI   119.78 (-0.30%)
BAC   30.08 (-1.80%)
DIS   122.46 (-0.73%)
GILD   73.78 (-1.23%)
S&P 500   3,082.70 (-1.08%)
DOW   26,627.70 (-1.22%)
QQQ   213.13 (-1.55%)
AAPL   283.04 (-3.28%)
FB   194.40 (-1.42%)
MSFT   165.60 (-2.69%)
GOOGL   1,360.73 (-2.14%)
AMZN   1,952.53 (-1.37%)
CGC   19.07 (-3.78%)
NVDA   263.90 (-1.40%)
MU   52.31 (-0.11%)
TSLA   713.98 (-8.32%)
AMD   45.25 (-4.72%)
T   36.63 (-1.27%)
ACB   1.49 (-1.32%)
F   7.22 (+0.14%)
NFLX   388.01 (+2.31%)
PRI   119.78 (-0.30%)
BAC   30.08 (-1.80%)
DIS   122.46 (-0.73%)
GILD   73.78 (-1.23%)
S&P 500   3,082.70 (-1.08%)
DOW   26,627.70 (-1.22%)
QQQ   213.13 (-1.55%)
AAPL   283.04 (-3.28%)
FB   194.40 (-1.42%)
MSFT   165.60 (-2.69%)
GOOGL   1,360.73 (-2.14%)
AMZN   1,952.53 (-1.37%)
CGC   19.07 (-3.78%)
NVDA   263.90 (-1.40%)
MU   52.31 (-0.11%)
TSLA   713.98 (-8.32%)
AMD   45.25 (-4.72%)
T   36.63 (-1.27%)
ACB   1.49 (-1.32%)
F   7.22 (+0.14%)
NFLX   388.01 (+2.31%)
PRI   119.78 (-0.30%)
BAC   30.08 (-1.80%)
DIS   122.46 (-0.73%)
GILD   73.78 (-1.23%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Invo BioscienceEndologixInterpace Diagnostics GroupSANUWAVE HealthArch Therapeutics
SymbolOTCMKTS:IVOBNASDAQ:ELGXNASDAQ:IDXGOTCMKTS:SNWVOTCMKTS:ARTH
Price Information
Current Price$0.26$1.43$8.67$0.29$0.22
52 Week RangeN/AHoldBuyN/ABuy
Analyst Ratings
Consensus RecommendationN/AHoldBuyN/ABuy
Consensus Price TargetN/A$4.80$6.67N/A$1.63
% Upside from Price TargetN/A235.66% upside-23.11% downsideN/A638.64% upside
Trade Information
Market Cap$40.90 million$25.83 million$34.69 million$85.49 million$41.12 million
Beta-0.960.232.05-1.560.3
Average Volume37,352720,07861,713442,857215,709
Sales & Book Value
Annual Revenue$490,000.00$143.37 million$21.90 million$1.85 millionN/A
Price / Sales83.480.181.5145.41N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($0.02) per share$3.83 per share$11.48 per share($0.10) per shareN/A
Price / Book-13.000.370.76-2.85N/A
Profitability
Net Income$-3,080,000.00$-64,760,000.00$-12,190,000.00$-11,630,000.00$-4,550,000.00
EPSN/A($2.19)($4.30)($0.08)N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E Ratio∞N/AN/AN/A22.00
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-166.95%-45.17%-77.55%-846.96%N/A
Return on Equity (ROE)N/A-68.69%-58.48%N/A-6,362.44%
Return on Assets (ROA)-85.23%-11.89%-31.60%-689.07%-113.76%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A2.70%0.57%N/AN/A
Current Ratio1.05%2.22%1.19%0.07%5.63%
Quick Ratio1.02%1.55%1.19%0.05%5.31%
Ownership Information
Institutional Ownership PercentageN/A71.39%N/A0.52%0.01%
Insider Ownership Percentage20.64%1.30%48.00%23.40%N/A
Miscellaneous
Employees252889148
Shares Outstanding157.38 million17.94 million3.82 million294.78 million186.90 million
Next Earnings Date4/21/2020 (Estimated)5/7/2020 (Estimated)3/17/2020 (Estimated)4/3/2020 (Estimated)N/A
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel